Last Updated on December 31, 2023 by The Health Master
Download NPPA notification No. S.O. 193(E) dt 11-01-2023, the link is given below: The National Pharmaceutical Pricing Authority (NPPA) has fixed the retail prices of 36 formulations under the Drugs (Prices Control) Order, 2013, vide S.O. 193(E) dt 11-01-2023 based on the decision of the 107th Authority meeting dated 11.01.2023.
This price fixation followed the decision of the 107th Authority meeting on January 11, 2022
The notification states as under:
In exercise of the powers conferred by paragraphs 5, 11 and 15 of the Drugs (Prices Control) Order, 2013, read with S.O. 1394(E) dated the 30th May, 2013 and S. O. 5249(E) dated 11th November, 2022 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority (hereinafter referred as NPPA), hereby fixes, the price as specified in column (6) of the table herein below as the retail price, exclusive of Goods and Services Tax, if any, in relation to the formulation specified in the corresponding entry in column (2) of the said Table with the strength, unit and name of manufacturer & marketing company, as specified in the corresponding entries in columns (3), (4) and (5) thereof;
Table
| Sl. No. | Name of the Formulation / Brand Name | Strength | Unit | Manufacturer & Marketing Company | Retail Price (Rs.) |
| (1) | (2) | (3) | (4) | (5) | (6) |
| 1. | Glimepiride, Voglibose & Metformin (Extended- release) tablets | Each uncoated bilayered tablet contains: Glimepiride IP 2mg, Voglibose IP 0.2mg Metformin Hydrochloride IP 500mg (as Extended- release) | 1 Tablet | M/s Akums Drugs & Pharmaceuticals Ltd. / M/s Apex Laboratories Pvt. Ltd. | 13.83 |
| 2. | Paracetamol, Phenylephrine Hydrochloride, Diphenhydrami ne Hydrochloride and Caffeine Tablets | Each uncoated tablet contains: Paracetamol IP 500mg Phenylephrine Hydrochloride IP 5mg Diphenhydramine Hydrochloride IP 25mg Caffeine (Anhydrous) IP 30mg | 1 Tablet | M/s Alicon Pharmaceuticals Pvt. Ltd. / M/s Dales Laboratories Pvt. Ltd. | 2.76 |
| 3. | Paracetamol, Phenylephrine and Chlorphenirami ne Tablets | Each film coated tablet contains: Paracetamol IP 500mg Phenylephrine Hydrochloride IP 10mg Chlorpheniramine maleate IP 2mg | 1 Tablet | M/s Akums Drugs & Pharmaceuticals Ltd. / M/s Torrent Pharmaceuticals Limited | 4.36 |
| 4. | Desvenlafaxine Extended Release and Clonazepam Tablets | Each uncoated bilayered tablet contains: Desvenlafaxine Succinate USP eq. to Desvenlafaxine 50mg (As extended-release form) Clonazepam IP 0.25mg | 1 Tablet | M/s Pure & Cure Healthcare Pvt. Ltd. / M/s Intas Pharmaceuticals Ltd. | 13.24 |
| 5. | Thiocolchicosid e, Aceclofenac and Paracetamol Tablet | Each film coated tablet contains: Thiocolchicoside IP 8mg Aceclofenac IP 100 mg Paracetamol IP 325 mg | 1 Tablet | M/s Ravenbhel Healthcare Pvt. Ltd. / M/s Intas Pharmaceuticals Ltd. | 24.78 |
| 6. | Telmisartan, Chlorthalidone & Metoprolol (ER) Tablets | Each film coated bilayered tablet contains: Telmisartan IP 40mg Chlorthalidone IP 12.5mg Metoprolol Succinate IP 23.75mg eq. to Metoprolol Tartrate (as Extended release) 25mg | 1 Tablet | M/s Ravenbhel Healthcare Pvt. Ltd. / M/s Abbott Healthcare Pvt. Ltd. | 10.90 |
| 7. | Telmisartan, Chlorthalidone & Metoprolol (ER) Tablets | Each film coated bilayered tablet contains: Telmisartan IP 40mg Chlorthalidone IP 12.5mg Metoprolol Succinate IP 47.50mg eq. to Metoprolol Tartrate (as Extended release) 50mg | 1 Tablet | M/s Ravenbhel Healthcare Pvt. Ltd. / M/s Abbott Healthcare Pvt. Ltd. | 13.15 |
| 8. | Rosuvastatin & Clopidogrel Capsules | Each Hard gelatin capsule cotains: Rosuvastatin Calcium IP eq. to Rosuvastatin 10mg Clopidogrel Bisulphate IP eq. to Clopidogrel 75mg | 1 Capsul e | M/s Windlas Biotech Limited. / M/s Modi- Mundipharma Pvt. Ltd. | 13.66 |
| 9. | Rosuvastatin & Clopidogrel Capsules | Each Hard gelatin capsule cotains: Rosuvastatin Calcium IP eq. to Rosuvastatin 20mg Clopidogrel Bisulphate IP eq. to Clopidogrel 75mg | 1 Capsul e | M/s Windlas Biotech Limited. / M/s Modi- Mundipharma Pvt. Ltd. | 16.96 |
| 10. | Rosuvastatin, Clopidogrel & Aspirin Capsule | Each Hard gelatin capsule cotains: Rosuvastatin Calcium IP eq. to Rosuvastatin 20mg Clopidogrel Bisulphate IP eq. to Clopidogrel 75mg Aspirin IP 75mg | 1 Capsul e | M/s Windlas Biotech Limited. / M/s Modi- Mundipharma Pvt. Ltd. | 20.53 |
| 11. | Montelukast and Acebrophylline (SR) Tablets | Each uncoated bilayered tablet contains: Montelukast Sodium IP eq. to Montelukast 10mg Acebrophylline 200mg (As Sustained release) | 1 Tablet | M/s Pure and Cure Healthcare Pvt. Ltd. / M/s Zydus Healthcare Limited | 16.12 |
| 12. | Pantoprazole Tablets IP | Each enteric coated tablet contains: Pantoprazole Sodium IP eq. to Pantoprazole 20mg | 1 Tablet | M/s Pure and Cure Healthcare Pvt. Ltd./ M/s Torrent Pharmaceuticals Limited | 6.68 |
Note:
(a) The manufacturer of the above-mentioned formulations, i.e., the “new drug” under paragraph 2(1)(u) of the DPCO, 2013 shall fix the retail price as specified in column (6) of the table hereinabove.
(b) The manufacturer may add Goods and Services Tax only if they have paid actually or it is payable to the Government on the retail price mentioned in column (6) of the above said table.
(c) The retail price for a pack of the aforesaid formulation shall be arrived at by the concerned manufacturer in accordance with the retail price specified in column (6) of the above table as per provisions contained in paragraph 11 of the DPCO, 2013.
The manufacturer shall issue a price list in Form–V from date of Notification as per paragraph 24 of the DPCO, 2013 to NPPA through IPDMS and submit a copy to State Drug Controller and dealers.
(d) As per para 24(4) of DPCO 2013, every retailer and dealer shall display price list and the supplementary price list, if any, as furnished by the manufacturer, on a conspicuous part of the premises where he carries on business in a manner so as to be easily accessible to any person wishing to consult the same.
(e) The above mentioned retail price is applicable only to the individual manufacturer / marketer as mentioned above i.e.. who have applied for the same by submitting Form-I for price fixation / revision as stipulated under DPCO, 2013 and subject to fulfilment of all the applicable statutory requirements as laid down by the Govt. under relevant statutes/ rules,
including manufacturing license permission from the competent authority, i.e., the central or state licensing authority, as may be applicable, by the concerned manufacturer/marketing company.
(f) In case the retail price of any of the aforesaid formulations is not complied with, as per the instant price notification and notes specified hereinabove, then the concerned manufacturer / marketing company shall be liable to deposit the overcharged amount along with the interest thereon under the provisions of the DPCO, 2013 read with the Essential Commodities Act, 1955.
(g) Consequent to the fixation of retail price of such formulation as specified in column (2) of the above table with the strength and name of Manufacturer & Marketing Companies specified in the corresponding entries in Column (3) & (5) thereof, the price order(s) fixing the retail price of the formulation with specified strength for that Manufacturer & Marketing
Companies as specified in corresponding entries in Columns (2), (3), and (5) thereof, if any, issued prior to this notification, stand superseded.
Latest on National Pharmaceutical Pricing Authority (NPPA)
Latest notifications – DPCO / NPPA
NPPA updated price lists: Download
Latest Notifications: EC Act (Essential Commodities Act)
FAQs – On DPCO: Drugs (Prices Control) Order, 2013
National List of Essential Medicines (NLEM)
NPPA revised Retail Price of 93 scheduled formulations: January 2023
NPPA fixes Retail Price of 4 scheduled formulations: January 2023
NPPA fixes retail price of 36 formulations: January 2023
NPPA fixes Retail Price of 10 formulations: December 2022
NPPA fixes Retail Price of 12 scheduled formulations: December 2022
NPPA revises Retail Price of 107 scheduled formulations: December 2022
Drug recall: Epinephrine API recalled due to this reason
Deadline for Medical Colleges to submit PG Admissions info: NMC
NPPA revised Retail Price of 93 scheduled formulations: January 2023
USFDA issues warning letter to Sun Pharma for its Gujarat plant
Tramadol: 3 Pharmaceutical Companies under scanner
NMC allows foreign medical graduates to finish internship in India
NABL suspends accreditation of 80 laboratories
NPPA fixes Retail Price of 4 scheduled formulations: January 2023
List of approved FDCs (Fixed Dose Combinations) Updated
List of approved New Drugs Updated
Latest Notifications regarding Pharmaceutical
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
